Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/10/17 → 26/02/18 |
Collaborative partners
- Vall d'Hebron Institut de Recerca (VHIR)
- Universitat Autònoma de Barcelona (UAB) (lead)
Validation of the capacity of SKL in bloodstream to cross BBB and its therapeutic use in neurodegenerative and demyelinating diseases
- Chillón Rodriguez, Miguel (Principal Investigator)
- Espinosa Parrilla, Juan Francisco (Investigator)
- Puig Ferrer, Meritxell (Investigator)